NOTCH1 and head and neck squamous cell carcinoma: A preclinical study found that blocking NOTCH1 with the γ-secretase inhibitor, DAPT, modifies the HNSCC CSC phenotype, reducing chemoresistance in tissues post chemotherapy, and also lymph node metastasis [102].